In this regard, PD-L1 expression, T-cell inflamed profile, and the TMB have been proposed as promising predictive biomarkers for HNSCC, while other candidate biomarkers not discussed in this review, such as circulating tumor cells and circulating tumor DNA, are under investigation. This evidence concerns the gene CD274 and neoplasm.